Browse > Article

Assessment of the Estrogenicity of Isoflavonoids, Using MCF-7-ERE-Luc Cells  

Joung, Ki-Eun (College of Pharmacy, Ewha Womans University)
Kim, Yeo-Woon (College of Pharmacy, Ewha Womans University)
Sheen, Yhun-Yhong (College of Pharmacy, Ewha Womans University)
Publication Information
Archives of Pharmacal Research / v.26, no.9, 2003 , pp. 756-762 More about this Journal
Abstract
In the current study, our research focused on the estrogenic activity of isoflavonoids, mainly genistein, biochanin A and daidzein. Genistein enhanced the reporter gene expression of MCF-7-ERE-Luc cells, at a concentration as low as 10 nM, with a concentration of 100 nM the achieved gene expression effects were similar to those of 10 pM 17$\beta$-estradiol. Based on the estrogenic activities of biochanin A and daidzein, hydroxyl groups at the 4 and 5 positions are needed for the maximal effect of the genistein. The estrogenic effects of these isoflavonoids were inhibited by the concomitant treatment with tamoxifen. The data showed that the estrogenic effects of isoflavonoids were mediated through estrogen receptors. When the isoflavonoids were tested as mixtures, the estrogenic effects were lower than the arithmetic sum of those induced by each individual isoflavonoid. The estrogenic potency of each isoflavonoid was presented at EC50 levels with a 17$\beta$-estradiol equivalent concentration (EEQ) based on the dose response of each chemical. The EC50s and EEQs of genistein, biochanin A and daidzein were 4.15, 0.89 and 0.18 $\mu$M, and 15.0, 5.12 and 1.83 $\mu$ M/M, respectively. Our data clearly demonstrated that the pERE-luciferase reporter gene assay was suited for the sensitive and quantitative measurement, and large scale screening, of the estrogenicity of chemicals in vitro.
Keywords
Genistein; Biochanin A; Daidzein; EEQ; $17{\beta}-Estradiol; ERE$;
Citations & Related Records

Times Cited By Web Of Science : 7  (Related Records In Web of Science)
Times Cited By SCOPUS : 8
연도 인용수 순위
1 Ansbacher, R., Selective estrogen receptor modulators. Am. J. Obstet. Gynecol., 181, 1036 (1999)   PUBMED
2 Brzezinski, A. and Debi, A., Phytoestrogens: the 'natural' selective estrogen receptor modulators? Eur. J. Obstet. Gynecol. Reprod. Biol., 85, 47-51 (1999)   DOI   ScienceOn
3 Cassidy, A., Bingham, S., and Setchell K. D., Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am. J. Clin. Nutr., 60, 333-340 (1994)   DOI   PUBMED
4 Choi, Y. H., Zhang, L., Lee, W. H., and Park, K. Y., Genistein-induced G2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells. Int. J. Oncol., 3, 391-396 (1998)
5 Fotsis, T., Pepper, M. S., Aktas, E., Breit, S., Rasku, S., Adlercreutz, H., Wahala, K., Montesano, R., and Schweigerer, L., Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res., 57, 2916-2921 (1997)   PUBMED
6 Jorgensen, M., Vendelbo, B., Skakkebaek, N. E., and Leffers, H., Assaying estrogenicity by quantitating the expression of endogenous estrogen-regulated genes. Environ. Health Perspect, 108, 403-412 (2000)   DOI   ScienceOn
7 Kuzumaki, T., Kobayashi, T., and Ishikawa, K., Genistein induces p21(Cip1/WAF1) expression and blocks the G1 to S phase transition in mouse fibroblast and melanoma cells. Biochem. Biophys. Res. Commun., 251, 291-295 (1998)   DOI   ScienceOn
8 Nishikawa, J., Saito, K., Goto, J., Dakeyama, F., Matsuo, M., and Nishihara, T., New screening methods for chemicals with hormonal activities using interaction of nuclear hormone receptor with coactivator. Toxico. Appl. Pharmacol., 154, 76-83 (1999)   DOI   ScienceOn
9 Sumpter, J. P. and Jobling, S., Vitellogenesis as a biomarker for estrogenic contamination of the aquatic environment. Environ. Health Perspect, 103,173-178 (1995)   DOI   PUBMED
10 Wang, T. T., Sathyamoorthy, N., and Phang, J. M., Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis, 17, 271-275 (1996)   DOI   ScienceOn
11 Fioravanti, L., Cappelletti, V., Miodini, P., Ronchi, E., Brivio, M., and Di Fronzo, G., Genistein in the control of breast cancer cell growth: insights into the mechanism of action in vitro. Cancer Lett., 130, 143-152 (1998)   DOI   PUBMED   ScienceOn
12 Gaido, K. W., Leonard, L. S., Lovell, S., Gould, J. C., Babai, D., Portier, C. J., and MacDonell, D. P., Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor transcription assay. Toxicol. Appl. Pharmacol., 143, 205-212 (1997)   DOI   ScienceOn
13 Morito,, K., Aomori T., Hirose, T., Kinjo J., Hasegawa, J., Ogawa, S., Inoue, S., Muramatsu, M., and Masamune, Y., Interaction of Phytoestrogens with Estrogen Receptors $\alpha$ and $\beta$ (II). Biol. Pharm. Bull., 25, 48-52 (2002)   DOI   ScienceOn
14 Soto, A. M., Sonnenschein, C., Chung, K. L., Fernandes, M. F., Olea, N., and Serrano, F. O. The E-SCREEN assay as a tool to identify estrogens : an update on estrogenic environmental pollutants. Environ. Health Perspect, 103,113-122 (1995)   DOI   PUBMED
15 Breinholt, V. and Larsen, J. C., Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified MCF7 cell proliferation assay. Chem. Res. Toxicol., 11, 622-629 (1998)   DOI   ScienceOn
16 Constantinou, A. I., Kamath, N., and Murley, J. S., Genistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells. Eur. J. Cancer, 34, 1927-1934 (1998)   DOI   ScienceOn
17 Andersen, H. R., Andersson, A. M., Arnold, S. F., Autrup, H., Barfoed, M., Beresford, N.A., Bjerregaard, P., Christiansen, L. B., Gissel, B, Hummel, R., Jorgensen, E. B., Korsgaard, B., Le Guevel, R., Leffers, H., McLachlan, J., Moller, A., Nielsen, J. B., Olea, N., Oles-Karasko, A., Pakdel, F., Pedersen, K. L., Perez, P., Skakkeboek, N. E., Sonnenschein, C., and Soto, A. M. et al., Comparison of short-term estrogenicity tests for identification of hormone-disrupting chemicals. Environ. Health Perspect, 107, 89-108 (1999)   DOI   PUBMED
18 Klein, K. O., Baron, J., Colli, M. J., McDonnell, D. P., and Cutler, G. B. Jr., Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay. J. Clin. Invest., 94, 2475-2480 (1994)   DOI   ScienceOn
19 Noroozi, M., Angerson, W. J., and Lean, M. E., Effects of flavonoids and vitamin C on oxidative DNA damage to human lymphocytes. Am. J. Clin. Nutr., 67, 1210-1218 (1998)   DOI   PUBMED
20 Bolger, R., Wiese, T. E., Ervin, K., Nestich, S., and Checovich, W., Rapid screening of environmental chemicals for estrogen receptor binding capacity. Environ. Health Prespect, 106, 551-557(1998)   DOI   ScienceOn
21 Xu, X., Duncan, A. M., Merz, B. E., and Kurzer, M. S., Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. Cancer Epidemiol. Biomarkers Prev., 7, 1101-1108 (1998)   PUBMED
22 Masamura, S., Santner, S. J., Heitjan, D. F., and Santen, R. J., Estrogen deprivation causes estradiol hypersensitivitiy in human breast cancer cells. J. Clin. Endocrinol. Metab., 80, 2918-2925 (1995)   DOI   ScienceOn
23 Weryha, G., Pascal-Vigneron, V., Klein, M., and Leclere, J., Selective estrogen receptor modulators. Curr. Opin. Rheumatol., 11, 301-306 (1999)   DOI   ScienceOn
24 Meyer, T., Koop, R., Von Angerer, E., Schonenberger, H., and Holler, E., A rapid luciferase transfection assay for transcription activation effects and stability control of estrogenic drugs in cell cultures. J. Cancer Res. Clin. Oncol., 120, 359-364 (1994)   DOI   ScienceOn
25 Andersson, A. M. and Skakkebaek, N. E., Exposure to exogenous estrogens in food: possible impact on human development and health. Eur. J. Endocrinol., 140, 477-485 (1999)   DOI   PUBMED
26 Hochner-Celnikier, D., Pharmacokinetics of raloxifene and its clinical applications. Eur. J. Obstet. Gynecol. Reprod. Biol., 85, 47-51 (1999)   DOI   ScienceOn
27 Delmas, P. D., Clinical use of selective estrogen receptor modulators. Bone, 25, 115-118 (1999)   DOI   PUBMED   ScienceOn